Detalhe da pesquisa
1.
Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid.
N Engl J Med;
389(3): 239-250, 2023 Jul 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37212440
2.
Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS).
Eur Heart J;
43(5): 391-400, 2022 Feb 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30938420
3.
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases.
Eur Heart J;
42(16): 1554-1568, 2021 04 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33825853
4.
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.
N Engl J Med;
379(11): 1007-1016, 2018 Sep 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30145929
5.
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis.
N Engl J Med;
379(1): 11-21, 2018 07 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29972753
6.
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization.
J Nucl Cardiol;
27(2): 659-673, 2020 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31468377
7.
Correction to: Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR).
Cardiovasc Drugs Ther;
34(6): 889, 2020 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32548685
8.
Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR).
Cardiovasc Drugs Ther;
34(3): 357-370, 2020 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32062791
9.
Amyloid cardiomyopathy.
Herz;
45(3): 267-271, 2020 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32107564
10.
Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner.
BMC Fam Pract;
21(1): 198, 2020 09 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32967612
11.
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization.
J Card Fail;
25(11): 854-865, 2019 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31473267
12.
Performance analysis of AL amyloidosis cardiac biomarker staging systems with special focus on renal failure and atrial arrhythmia.
Haematologica;
104(7): 1451-1459, 2019 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30655373
13.
Prognostic value of novel imaging parameters derived from standard cardiovascular magnetic resonance in high risk patients with systemic light chain amyloidosis.
J Cardiovasc Magn Reson;
21(1): 53, 2019 08 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31434577
14.
[What gnaws at the heart and gets on the nerves]. / Was am Herzen nagt und auf die Nerven geht.
Internist (Berl);
59(11): 1208-1213, 2018 Nov.
Artigo
em Alemão
| MEDLINE
| ID: mdl-30039176
15.
Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging.
J Card Fail;
28(7): e1-e4, 2022 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34217819
16.
Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up.
Haematologica;
102(8): 1424-1431, 2017 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28522573
17.
Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.
J Nucl Cardiol;
28(4): 1769-1774, 2021 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34196911
18.
Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.
J Nucl Cardiol;
28(4): 1761-1762, 2021 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34259978
19.
Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization.
J Nucl Cardiol;
28(4): 1763-1767, 2021 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34279803
20.
In vivo detection of nerve injury in familial amyloid polyneuropathy by magnetic resonance neurography.
Brain;
138(Pt 3): 549-62, 2015 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25526974